providing novel treatments and standardising cll biomarker testing across the world
Published 7 years ago • 37 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
2:49
assessing parameters and standardising biomarker detection in cll
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
1:36
the importance of genomic testing when making treatment decisions in cll
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
6:25
novel tools to monitor the immune system in lymphoma clinical trials
-
1:08:41
immunophenotyping of acute leukemia - part 2 of 4
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
2:29
the measurement of molecular biomarkers to aid cll treatment
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:43
biomarker-guided therapy in cll
-
0:45
key trials in cll and designing a concept for treatment
-
1:20
novel testing techniques in scd: cell-by-cell magnetization analysis
-
3:16
prognostic markers for the treatment of cll
-
1:28
the future of cll treatment
-
1:00
using molecular features to determine appropriate treatment strategies for patients with cll
-
0:53
the future of cll treatment
-
5:21
examples of biology informing treatment decisions in cll
-
1:00
insights into the future of the cll treatment landscape
-
2:00
associated toxicities of novel therapies for cll
-
2:18
tools to improve the outcomes of patients with cll affected by covid-19